At a glance
ClinicalIndex Comparison RecordN/ACompleted· 113 enrolled
Drug / intervention
clomiphene citrate +highly purified uFSH +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Minimal Stimulation or Clomiphene Citrate as First Line Therapy in Women With Polycystic Ovary Syndrome
In Brief
A clinical study evaluating clomiphene citrate +highly purified uFSH and clomiphene citrate for Polycystic Ovary Syndrome. Completed, enrolled 113 participants across 1 site.
Detailed Summary
The purpose of this study is to compare and determine the the efficacy of minimal stimulation and clomiphene citrate(CC) as the first-line treatment in infertile women with Polycystic Ovary Syndrome(PCOS).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPolycystic Ovary Syndrome
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2008
Primary CompletionApr 2010
First PostedJul 2010
TodayJul 2026
First PostedJul 7, 2010
Enrollment StartAug 1, 2008
Primary CompletionApr 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 16.0 years ago
Interventions
clomiphene citrate +highly purified uFSHdrug
clomiphene citratedrug